- All
- Important
- Financial Update
- Fund Raise
- Board Meeting
- Dividend/Bonus
- JV/Acquisition
- Investor Meet
- Insider Trade
- Pledging
- Others
Glenmark Pharmaceuticals Limited — Updates, 16-03-2026: Press Release
16-03-2026 | 08:43 am
16-03-2026 | 08:43 am
Glenmark's US subsidiary launched Potassium Phosphates Injection USP, entering the institutional channel. This new generic drug targets a market with annual sales of approximately $50.7 million (~422.5 Cr), potentially boosting revenue.
No comments yet. Be the first to comment!